Change in diabetic retinopathy through 2 years secondary analysis of a randomized clinical trial comparing aflibercept, bevacizumab, and ranibizumab

Susan B. Bressler, Danni Liu*, Adam R. Glassman, Barbara A. Blodi, Alessandro A. Castellarin, Lee Merrill Jampol, Paul L. Kaufman, Michele Melia, Harinderjit Singh, John A. Wells

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Fingerprint Dive into the research topics of 'Change in diabetic retinopathy through 2 years secondary analysis of a randomized clinical trial comparing aflibercept, bevacizumab, and ranibizumab'. Together they form a unique fingerprint.

Medicine & Life Sciences